文献速递呼吸衰竭与机械通气

经鼻高流量氧疗对急性低氧性呼吸衰竭的生理效应

Physiologic Effects of High-Flow Nasal Cannula in Acute Hypoxemic Respiratory Failure.
PubMed 文献 · Am J Respir Crit Care Med · 2017-01-01
一句话结论在急性低氧性呼吸衰竭非插管患者中,与面罩相比,经鼻高流量氧疗(40 L/min)改善氧合并降低呼吸功和分钟通气量,同时增加呼气末肺容积和动态肺顺应性。

本研究为前瞻性随机交叉研究,纳入15例急性低氧性呼吸衰竭非插管ICU患者(年龄60±14岁,PaO2/设定FiO2 130±35 mm Hg),随机应用经鼻高流量氧疗(40 L/min)与标准非封闭面罩(相同临床设定FiO2),每阶段20分钟。结果显示,与面罩相比,经鼻高流量氧疗显著改善氧合(P<0.001),降低呼吸频率(P<0.01)、食管压波动(ΔPes,P<0.01)和压力时间乘积(P<0.001);在动脉血二氧化碳分压和pH不变的情况下降低分钟通气量(P<0.001),增加呼气末肺容积(P<0.001),潮气量无变化(P=0.44),潮气量与ΔPes比值(动态肺顺应性估计)增加(P<0.05),通气分布更均匀(P<0.01)。作者认为这些生理效应可能解释经鼻高流量氧疗的临床疗效。

要点

  • 在急性低氧性呼吸衰竭非插管患者中,经鼻高流量氧疗(40 L/min)较面罩显著改善氧合(P<0.001)并降低呼吸频率(P<0.01)。
  • 经鼻高流量氧疗降低吸气努力:ΔPes(P<0.01)和压力时间乘积(P<0.001)均较面罩显著下降。
  • 经鼻高流量氧疗在动脉血二氧化碳分压和pH不变(P=0.27和P=0.23)的情况下降低分钟通气量(P<0.001)。
  • 经鼻高流量氧疗增加呼气末肺容积(P<0.001)和动态肺顺应性估计值(潮气量/ΔPes比值,P<0.05),潮气量无变化(P=0.44)。
  • 经鼻高流量氧疗使通气分布更均匀(P<0.01)。

适用人群与场景

  • 纳入ICU的非插管急性低氧性呼吸衰竭患者,PaO2/设定FiO2≤300 mm Hg。
  • 共纳入15例,年龄60±14岁,PaO2/设定FiO2为130±35 mm Hg,7例(47%)有双侧肺浸润。

研究设计与关键结果

  • 前瞻性随机交叉研究,纳入15例非插管急性低氧性呼吸衰竭患者,随机应用经鼻高流量氧疗(40 L/min)与标准非封闭面罩(相同临床设定FiO2),每阶段20分钟。
  • 与面罩相比,经鼻高流量氧疗显著改善氧合(P<0.001),降低呼吸频率(P<0.01)、ΔPes(P<0.01)和压力时间乘积(P<0.001)。
  • 经鼻高流量氧疗期间分钟通气量降低(P<0.001),动脉血二氧化碳分压和pH不变(P=0.27和P=0.23)。
  • 经鼻高流量氧疗增加呼气末肺容积(P<0.001),潮气量无变化(P=0.44),潮气量/ΔPes比值增加(P<0.05),通气分布更均匀(P<0.01)。

证据类型、等级与局限

  • 证据类型:前瞻性随机交叉研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,经鼻高流量氧疗产生的多种生理效应包括降低吸气努力、改善肺容积和顺应性,这些益处可能解释其临床疗效。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

RATIONALE: High-flow nasal cannula (HFNC) improves the clinical outcomes of nonintubated patients with acute hypoxemic respiratory failure (AHRF).

OBJECTIVES: To assess the effects of HFNC on gas exchange, inspiratory effort, minute ventilation, end-expiratory lung volume, dynamic compliance, and ventilation homogeneity in patients with AHRF.

METHODS: This was a prospective randomized crossover study in nonintubated patients with AHRF with PaO2/setFiO2 less than or equal to 300 mm Hg admitted to the intensive care unit. We randomly applied HFNC set at 40 L/min compared with a standard nonocclusive facial mask at the same clinically set FiO2 (20 min/step).

MEASUREMENTS AND MAIN RESULTS: Toward the end of each phase, we measured arterial blood gases, inspiratory effort, and work of breathing by esophageal pressure swings (ΔPes) and pressure time product, and we estimated changes in lung volumes and ventilation homogeneity by electrical impedance tomography. We enrolled 15 patients aged 60 ± 14 years old with PaO2/setFiO2 130 ± 35 mm Hg. Seven (47%) had bilateral lung infiltrates. Compared with the facial mask, HFNC significantly improved oxygenation (P < 0.001) and lowered respiratory rate (P < 0.01), ΔPes (P < 0.01), and pressure time product (P < 0.001). During HFNC, minute ventilation was reduced (P < 0.001) at constant arterial CO2 tension and pH (P = 0.27 and P = 0.23, respectively); end-expiratory lung volume increased (P < 0.001), and tidal volume did not change (P = 0.44); the ratio of tidal volume to ΔPes (an estimate of dynamic lung compliance) increased (P < 0.05); finally, ventilation distribution was more homogeneous (P < 0.01).

CONCLUSIONS: In patients with AHRF, HFNC exerts multiple physiologic effects including less inspiratory effort and improved lung volume and compliance. These benefits might underlie the clinical efficacy of HFNC.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Mauri T, Turrini C, Eronia N, et al. Physiologic Effects of High-Flow Nasal Cannula in Acute Hypoxemic Respiratory Failure. Am J Respir Crit Care Med. 2017. PMID: 27997805. doi:10.1164/rccm.201605-0916OC

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。